{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:11:31Z","timestamp":1790982691284,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaip.2017.06.031","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T05:46:09Z","timestamp":1504676769000},"page":"1169-1178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":501,"title":["Fatal Anaphylaxis: Mortality Rate and Risk Factors"],"prefix":"10.1016","volume":"5","author":[{"given":"Paul J.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Jerschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thisanayagam","family":"Umasunthar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.06.031_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","article-title":"Case fatality and population mortality associated with anaphylaxis in the United States","volume":"133","author":"Ma","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jaci.2007.05.026","article-title":"The prevalence of food allergy: a meta-analysis","volume":"120","author":"Rona","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1542\/peds.2009-1210","article-title":"Food allergy among children in the United States","volume":"124","author":"Branum","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2017.06.031_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1398-9995.2012.02829.x","article-title":"Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10","volume":"67","author":"Tanno","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib6","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2008.10.049","article-title":"Anaphylaxis fatalities and admissions in Australia","volume":"123","author":"Liew","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/00313020600820831","article-title":"Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005","volume":"38","author":"Low","year":"2006","journal-title":"Pathology"},{"key":"10.1016\/j.jaip.2017.06.031_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2007.07.040","article-title":"Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005","volume":"120","author":"Poulos","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib10","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/cea.12748","article-title":"Increases in anaphylaxis fatalities in Australia from 1997 to 2013","volume":"46","author":"Mullins","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1710-1492-10-38","article-title":"Anaphylaxis-related deaths in Ontario: a retrospective review of cases from 1986 to 2011","volume":"10","author":"Xu","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/all.12426","article-title":"Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis","volume":"69","author":"Reitter","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13023-016-0554-4","article-title":"Fatal anaphylaxis registries data support changes in the WHO anaphylaxis mortality coding rules","volume":"12","author":"Tanno","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2017.06.031_bib16","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2015.11.015","article-title":"Anaphylaxis in children and adolescents: the European Anaphylaxis Registry","volume":"137","author":"Grabenhenrich","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/all.12475","article-title":"First European data from the network of severe allergic reactions (NORA)","volume":"69","author":"Worm","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/ACI.0000000000000305","article-title":"Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis?","volume":"16","author":"Turner","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1081-1206(10)60315-8","article-title":"Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006","volume":"101","author":"Lin","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib20","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaci.2015.10.027","article-title":"Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012","volume":"137","author":"Jeppesen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"1","author":"Ring","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2017.06.031_bib22","first-page":"206","article-title":"Analysis of 59 anaphylactic death cases","volume":"31","author":"Li","year":"2015","journal-title":"Fa Yi Xue Za Zhi"},{"key":"10.1016\/j.jaip.2017.06.031_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2008.12.007","article-title":"Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006","volume":"186","author":"Shen","year":"2009","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jaip.2017.06.031_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PAF.0b013e3181c0e7bb","article-title":"Postmortem findings after anaphylactic reactions to drugs in Turkey","volume":"30","author":"Yilmaz","year":"2009","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.jaip.2017.06.031_bib25","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1213\/ANE.0b013e31822d45ac","article-title":"Allergic reactions during anesthesia at a large United States referral center","volume":"113","author":"Gurrieri","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2017.06.031_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MEJ.0000000000000155","article-title":"Acute allergic reactions in the emergency department: characteristics and management practices","volume":"22","author":"Hitti","year":"2015","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.jaip.2017.06.031_bib27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaip.2015.05.012","article-title":"Drug-induced anaphylaxis in Latin American Countries","volume":"3","author":"Jares","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.06.031_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2016.02.008","article-title":"Antibiotics are the most commonly identified cause of perioperative hypersensitivity reactions","volume":"4","author":"Kuhlen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.06.031_bib29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaip.2015.07.013","article-title":"Utility of ICD-9-CM codes for identification of allergic drug reactions","volume":"4","author":"Saff","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.06.031_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jemermed.2004.11.028","article-title":"Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions","volume":"28","author":"Smit","year":"2005","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.jaip.2017.06.031_bib32","doi-asserted-by":"crossref","first-page":"429534","DOI":"10.1155\/2015\/429534","article-title":"Clinical characteristics of inpatients with anaphylaxis in China","volume":"2015","author":"Tang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jaip.2017.06.031_bib33","first-page":"367","article-title":"Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland","volume":"111","author":"Worm","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jaip.2017.06.031_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1081-1206(10)60401-2","article-title":"Epidemiologic and clinical features of anaphylaxis in Korea","volume":"100","author":"Yang","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib35","first-page":"22","article-title":"Predictors of the severity and serious outcomes of anaphylaxis in Korean adults: a multicenter retrospective case study","volume":"7","author":"Ye","year":"2015","journal-title":"Ann Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2017.06.031_bib36","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacr.2014.09.032","article-title":"Contrast is the new penicillin, and possibly worse","volume":"12","author":"Scheinfeld","year":"2015","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.jaip.2017.06.031_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.iac.2009.04.002","article-title":"The pholcodine story","volume":"29","author":"Florvaag","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.06.031_bib38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1398-9995.2012.02803.x","article-title":"Pholcodine in cough medicines and IgE-sensitization in the EU: an urgent task","volume":"67","author":"Florvaag","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1398-9995.2010.02518.x","article-title":"IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market","volume":"66","author":"Florvaag","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1398-9995.2009.02193.x","article-title":"National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study","volume":"65","author":"Johansson","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1398-9995.2009.01983.x","article-title":"Pholcodine caused anaphylaxis in Sweden 30 years ago","volume":"64","author":"Johansson","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.iac.2015.01.001","article-title":"Fatal and near-fatal anaphylaxis: factors that can worsen or contribute to fatal outcomes","volume":"35","author":"Greenberger","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.06.031_bib43","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","article-title":"Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis","volume":"131","author":"Lee","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0196-0644(88)80300-7","article-title":"Adverse drug reaction processing in the United States and its dependence on physician reporting: zomepirac (Zomax) as a case in point","volume":"17","author":"Corre","year":"1988","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jaip.2017.06.031_bib46","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/cea.12211","article-title":"Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis","volume":"43","author":"Umasunthar","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib47","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/cea.12477","article-title":"Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis","volume":"45","author":"Umasunthar","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.iac.2015.01.007","article-title":"Anaphylaxis to insect stings","volume":"35","author":"Golden","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.06.031_bib49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1369-7625.2008.00506.x","article-title":"When doctors disagree: a qualitative study of doctors' and parents' views on the risks of childhood food allergy","volume":"11","author":"Hu","year":"2008","journal-title":"Health Expect"},{"key":"10.1016\/j.jaip.2017.06.031_bib50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2011.01.039","article-title":"Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants","volume":"127","author":"Osborne","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib51","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJMoa1514210","article-title":"Randomized trial of introduction of allergenic foods in breast-fed infants","volume":"374","author":"Perkin","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.06.031_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199208063270603","article-title":"Fatal and near-fatal anaphylactic\u00a0reactions\u00a0to food in children and adolescents","volume":"327","author":"Sampson","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.06.031_bib53","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2006.12.622","article-title":"Further fatalities caused by anaphylactic reactions to food, 2001-2006","volume":"119","author":"Bock","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib54","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaci.2007.01.021","article-title":"Further fatal allergic reactions to food in the United Kingdom, 1999-2006","volume":"119","author":"Pumphrey","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib55","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jaip.2016.05.005","article-title":"The emperor has no symptoms: the risks of a blanket approach to using epinephrine autoinjectors for all allergic reactions","volume":"4","author":"Turner","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.06.031_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1398-9995.2008.01926.x","article-title":"Adrenaline for the treatment of anaphylaxis: cochrane systematic review","volume":"64","author":"Sheikh","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1742-6723.2006.00831.x","article-title":"Anaphylaxis: clinical concepts and research priorities","volume":"18","author":"Brown","year":"2006","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jaip.2017.06.031_bib58","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1172\/JCI109936","article-title":"Physiologic manifestations of human anaphylaxis","volume":"66","author":"Smith","year":"1980","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2017.06.031_bib59","series-title":"Advances in Anaphylaxis Management","first-page":"32","article-title":"Risk factors for fatal anaphylaxis","author":"Pumphrey","year":"2014"},{"key":"10.1016\/j.jaip.2017.06.031_bib60","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12924","article-title":"Can we identify patients at risk of life-threatening allergic reactions to food?","volume":"71","author":"Turner","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.anai.2014.06.023","article-title":"Safety and clinical predictors of reacting to extensively heated cow's milk challenge in cow's milk-allergic children","volume":"113","author":"Mehr","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib62","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/pai.12093","article-title":"Safety of food challenges to extensively heated egg in egg-allergic children: a prospective cohort study","volume":"24","author":"Turner","year":"2013","journal-title":"Pediatric Allergy Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib63","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.06.031_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaip.2016.08.013","article-title":"Increasing emergency department visits for anaphylaxis, 2005-2014","volume":"5","author":"Motosue","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.06.031_bib65","first-page":"281","article-title":"Pediatric anaphylaxis: triggers, clinical features, and treatment in a tertiary-care hospital","volume":"33","author":"Manuyakorn","year":"2015","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.mcna.2005.08.006","article-title":"Insect sting allergy","volume":"90","author":"Graft","year":"2006","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaip.2017.06.031_bib67","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib68","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2014.11.035","article-title":"Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels","volume":"136","author":"Zanotti","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib70","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaip.2017.03.019","article-title":"Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at risk patients","volume":"5","author":"Vos","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.06.031_bib71","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2013.10.033","article-title":"Basal platelet-activating factor acetylhydrolase: prognostic marker of severe Hymenoptera venom anaphylaxis","volume":"133","author":"Pravettoni","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.06.031_bib72","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/all.12210","article-title":"Immunotherapy for hymenoptera venom allergy: too expensive for European health care?","volume":"68","author":"Boyle","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.06.031_bib73","first-page":"CD008838","article-title":"Venom immunotherapy for preventing allergic reactions to insect stings","volume":"10","author":"Boyle","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2017.06.031_bib74","doi-asserted-by":"crossref","DOI":"10.3310\/hta16120","article-title":"A\u00a0systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen for the treatment of bee and wasp venom allergy","volume":"16","author":"Hockenhull","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaip.2017.06.031_bib75","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1067\/mai.2002.125827","article-title":"Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom","volume":"110","author":"Oude Elberink","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817305159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817305159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:11Z","timestamp":1761973991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817305159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213219817305159"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.06.031","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal Anaphylaxis: Mortality Rate and Risk Factors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}